<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 10 Jun 2026 16:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: INGRAM DOUGLAS S</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+INGRAM+DOUGLAS+S/26630327.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630327.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+INGRAM+DOUGLAS+S/26630327.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: INGRAM DOUGLAS S</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+INGRAM+DOUGLAS+S/26630327.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630327.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+INGRAM+DOUGLAS+S/26630327.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Murcko Mark</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Murcko+Mark/26630330.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630330.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Murcko+Mark/26630330.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Murcko Mark</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Murcko+Mark/26630330.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630330.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Murcko+Mark/26630330.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Borisy Alexis</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Borisy+Alexis/26630332.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630332.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Borisy+Alexis/26630332.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Borisy Alexis</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Borisy+Alexis/26630332.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630332.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Borisy+Alexis/26630332.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: HILL LINDA A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+HILL+LINDA+A/26630333.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630333.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+HILL+LINDA+A/26630333.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: HILL LINDA A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+HILL+LINDA+A/26630333.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630333.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+HILL+LINDA+A/26630333.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: COATS LONNEL</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+COATS+LONNEL/26630334.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630334.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+COATS+LONNEL/26630334.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: COATS LONNEL</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+COATS+LONNEL/26630334.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630334.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+COATS+LONNEL/26630334.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Dable Habib J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Dable+Habib+J/26630336.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630336.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Dable+Habib+J/26630336.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Dable Habib J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Dable+Habib+J/26630336.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630336.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Dable+Habib+J/26630336.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Mazumdar Claire</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Mazumdar+Claire/26630341.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630341.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Mazumdar+Claire/26630341.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  4          Relay Therapeutics, Inc.  For: Jun 09  Filed by: Mazumdar Claire</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Mazumdar+Claire/26630341.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630341.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09++Filed+by%3A+Mazumdar+Claire/26630341.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</link>
   <description>&lt;p&gt;Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $10.00 price target on Nuvation Bio Inc (NYSE: NUVB).&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;We view the acquisition as a positive signal for small molecules and targeted oncology. Names we cover in the space include NUVB, EXEL (MO, $50 PT), RLAY (MO, $21 PT), FHTX (MO, $9 PT), ACRV (MO, $13 PT). We do not view NUVB's zidesamtinib as meaningfully differentiated from NUVB's Ibtrozi, which has a 1-year head start in 2L and more in 1L ROS1+ NSCLC, and remain bullish on the Ibtrozi launch trajectory as 1L patient stacking becomes more meaningful.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</guid>
   <pubDate>Wed, 10 Jun 2026 05:19:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FHTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NUVB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</link>
   <description>&lt;p&gt;Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $10.00 price target on Nuvation Bio Inc (NYSE: NUVB).&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;We view the acquisition as a positive signal for small molecules and targeted oncology. Names we cover in the space include NUVB, EXEL (MO, $50 PT), RLAY (MO, $21 PT), FHTX (MO, $9 PT), ACRV (MO, $13 PT). We do not view NUVB's zidesamtinib as meaningfully differentiated from NUVB's Ibtrozi, which has a 1-year head start in 2L and more in 1L ROS1+ NSCLC, and remain bullish on the Ibtrozi launch trajectory as 1L patient stacking becomes more meaningful.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</guid>
   <pubDate>Wed, 10 Jun 2026 05:19:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FHTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NUVB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</link>
   <description>&lt;p&gt;Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $10.00 price target on Nuvation Bio Inc (NYSE: NUVB).&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;We view the acquisition as a positive signal for small molecules and targeted oncology. Names we cover in the space include NUVB, EXEL (MO, $50 PT), RLAY (MO, $21 PT), FHTX (MO, $9 PT), ACRV (MO, $13 PT). We do not view NUVB's zidesamtinib as meaningfully differentiated from NUVB's Ibtrozi, which has a 1-year head start in 2L and more in 1L ROS1+ NSCLC, and remain bullish on the Ibtrozi launch trajectory as 1L patient stacking becomes more meaningful.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</guid>
   <pubDate>Wed, 10 Jun 2026 05:19:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FHTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NUVB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</link>
   <description>&lt;p&gt;Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $10.00 price target on Nuvation Bio Inc (NYSE: NUVB).&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;We view the acquisition as a positive signal for small molecules and targeted oncology. Names we cover in the space include NUVB, EXEL (MO, $50 PT), RLAY (MO, $21 PT), FHTX (MO, $9 PT), ACRV (MO, $13 PT). We do not view NUVB's zidesamtinib as meaningfully differentiated from NUVB's Ibtrozi, which has a 1-year head start in 2L and more in 1L ROS1+ NSCLC, and remain bullish on the Ibtrozi launch trajectory as 1L patient stacking becomes more meaningful.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</guid>
   <pubDate>Wed, 10 Jun 2026 05:19:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FHTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NUVB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</link>
   <description>&lt;p&gt;Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $10.00 price target on Nuvation Bio Inc (NYSE: NUVB).&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;We view the acquisition as a positive signal for small molecules and targeted oncology. Names we cover in the space include NUVB, EXEL (MO, $50 PT), RLAY (MO, $21 PT), FHTX (MO, $9 PT), ACRV (MO, $13 PT). We do not view NUVB's zidesamtinib as meaningfully differentiated from NUVB's Ibtrozi, which has a 1-year head start in 2L and more in 1L ROS1+ NSCLC, and remain bullish on the Ibtrozi launch trajectory as 1L patient stacking becomes more meaningful.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Nuvation+Bio+%28NUVB%29+Reiterated+at+Market+Outperform+by+Citizens+Amid+Acquisition+by+GSK/26625792.html</guid>
   <pubDate>Wed, 10 Jun 2026 05:19:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FHTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NUVB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  8-K        Relay Therapeutics, Inc.  For: Jun 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09/26624240.html</link>
   <description>si-local-file:///var/storage/secattach/20260609/26624240.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09/26624240.html</guid>
   <pubDate>Tue, 09 Jun 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Form  8-K        Relay Therapeutics, Inc.  For: Jun 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09/26624240.html</link>
   <description>si-local-file:///var/storage/secattach/20260609/26624240.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Relay+Therapeutics%2C+Inc.++For%3A+Jun+09/26624240.html</guid>
   <pubDate>Tue, 09 Jun 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.40271399</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June</title>
   <link>http://www.streetinsider.com/Press+Releases/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</link>
   <description>&lt;p&gt;CAMBRIDGE, Mass., May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=ZYWCIWUEtghZi294uIlvtxu8YmzeO9PqOc04XDSnyN-zpngpEqv1MPjHripI7O5OhD4dqoxN1PSGe2FyjmqrRbIFAklYr-msGCTfYyJlMaY=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Relay Therapeutics, Inc.&lt;/a&gt; (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in June:&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 12:45 p.m. ET&lt;/li&gt;&lt;li&gt;Goldman Sachs 47&lt;sup&gt;th&lt;/sup&gt; Annual Global Healthcare Conference on Monday, June 8, 2026 at 8:40 a.m. ET&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</guid>
   <pubDate>Wed, 27 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June</title>
   <link>http://www.streetinsider.com/Press+Releases/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</link>
   <description>&lt;p&gt;CAMBRIDGE, Mass., May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=ZYWCIWUEtghZi294uIlvtxu8YmzeO9PqOc04XDSnyN-zpngpEqv1MPjHripI7O5OhD4dqoxN1PSGe2FyjmqrRbIFAklYr-msGCTfYyJlMaY=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Relay Therapeutics, Inc.&lt;/a&gt; (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in June:&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 12:45 p.m. ET&lt;/li&gt;&lt;li&gt;Goldman Sachs 47&lt;sup&gt;th&lt;/sup&gt; Annual Global Healthcare Conference on Monday, June 8, 2026 at 8:40 a.m. ET&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</guid>
   <pubDate>Wed, 27 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</link>
   <description>&lt;p&gt;CAMBRIDGE, Mass., May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=ZYWCIWUEtghZi294uIlvtxu8YmzeO9PqOc04XDSnyN-zpngpEqv1MPjHripI7O5OhD4dqoxN1PSGe2FyjmqrRbIFAklYr-msGCTfYyJlMaY=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Relay Therapeutics, Inc.&lt;/a&gt; (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in June:&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 12:45 p.m. ET&lt;/li&gt;&lt;li&gt;Goldman Sachs 47&lt;sup&gt;th&lt;/sup&gt; Annual Global Healthcare Conference on Monday, June 8, 2026 at 8:40 a.m. ET&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</guid>
   <pubDate>Wed, 27 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
  <item>
   <title>Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</link>
   <description>&lt;p&gt;CAMBRIDGE, Mass., May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=ZYWCIWUEtghZi294uIlvtxu8YmzeO9PqOc04XDSnyN-zpngpEqv1MPjHripI7O5OhD4dqoxN1PSGe2FyjmqrRbIFAklYr-msGCTfYyJlMaY=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Relay Therapeutics, Inc.&lt;/a&gt; (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in June:&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 12:45 p.m. ET&lt;/li&gt;&lt;li&gt;Goldman Sachs 47&lt;sup&gt;th&lt;/sup&gt; Annual Global Healthcare Conference on Monday, June 8, 2026 at 8:40 a.m. ET&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Relay+Therapeutics+to+Participate+in+Two+Upcoming+Investor+Conferences+in+June/26557706.html</guid>
   <pubDate>Wed, 27 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RLAY</category>
   	  </item>
 </channel>
</rss>
